Global Medical Inhaled Nitric Oxide Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Medical Inhaled Nitric Oxide Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Medical Inhaled Nitric Oxide market size was valued at US$ 1183 million in 2024 and is forecast to a readjusted size of USD 2119 million by 2031 with a CAGR of 8.8% during review period.

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator). Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

The main medical inhaled Nitric Oxide players include Mallinckrodt, Linde, Air Liquide, etc. The top three Medical Inhaled Nitric Oxide players account for approximately 95% of the total global market. The global medical inhaled Nitric Oxide are mainly produced in United States and Europe, they occupied for a share about 95%. North America is the largest consumer market, accounting for about 77%, followed by Europe and Asia-Pacific, with around 16% and 6% market share respectively.

This report is a detailed and comprehensive analysis for global Medical Inhaled Nitric Oxide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by NO Concentration and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Medical Inhaled Nitric Oxide market size and forecasts, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2020-2031

Global Medical Inhaled Nitric Oxide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2020-2031

Global Medical Inhaled Nitric Oxide market size and forecasts, by NO Concentration and by Application, in consumption value ($ Million), sales quantity (M L), and average selling prices (US$/L), 2020-2031

Global Medical Inhaled Nitric Oxide market shares of main players, shipments in revenue ($ Million), sales quantity (M L), and ASP (US$/L), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Medical Inhaled Nitric Oxide

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Medical Inhaled Nitric Oxide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt, Linde, Air Liquide, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Medical Inhaled Nitric Oxide market is split by NO Concentration and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by NO Concentration, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by NO Concentration
800 ppm
100 ppm
Others

Market segment by Application
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Other Diseases

Major players covered
Mallinckrodt
Linde
Air Liquide

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Medical Inhaled Nitric Oxide product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Medical Inhaled Nitric Oxide, with price, sales quantity, revenue, and global market share of Medical Inhaled Nitric Oxide from 2020 to 2025.

Chapter 3, the Medical Inhaled Nitric Oxide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Medical Inhaled Nitric Oxide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by NO Concentration and by Application, with sales market share and growth rate by NO Concentration, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Medical Inhaled Nitric Oxide market forecast, by regions, by NO Concentration, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Inhaled Nitric Oxide.

Chapter 14 and 15, to describe Medical Inhaled Nitric Oxide sales channel, distributors, customers, research findings and conclusion.